NCBI National Center for Biotechnology Information |
4B6L: Discovery of Oral Polo-Like Kinase (PLK) Inhibitors with Enhanced Selectivity Profile using Residue Targeted Drug Design | ||||||||||||||||||
* Click molecule labels to explore molecular sequence information.
|